Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid. [PDF]
Islam M, Hoggard N, Hadjivassiliou M.
europepmc +1 more source
Chenodeoxycholic acid triggers gastric mucosal injury by inducing apoptosis and FXR activation. [PDF]
Peng S, Sun R, Liu H, Wang B, Li Y.
europepmc +1 more source
Chenodeoxycholic Acid (CDCA) Promoted Intestinal Epithelial Cell Proliferation by Regulating Cell Cycle Progression and Mitochondrial Biogenesis in IPEC-J2 Cells. [PDF]
Xu L +9 more
europepmc +1 more source
Significant Reduction of Chenodeoxycholic Acid and Glycochenodeoxycholic Acid in the Elderly with Severe COVID-19. [PDF]
Liu S +13 more
europepmc +1 more source
Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway. [PDF]
Zhang Y +6 more
europepmc +1 more source
Multiomics analysis revealed the regulatory role of chenodeoxycholic acid in fatty acid metabolism and lipid homeostasis. [PDF]
Li L +8 more
europepmc +1 more source
Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid. [PDF]
Tang YP +5 more
europepmc +1 more source
A novel link between enhanced chenodeoxycholic acid synthesis and multi-walled carbon nanotubes-induced proliferation inhibition and apoptosis in human ocular cells. [PDF]
Liang Y +5 more
europepmc +1 more source
Never Late: Cerebrotendinous Xanthomatosis and Improvements in Neurocognitive Functions in an Adult Patient on Chenodeoxycholic Acid Treatment. [PDF]
Sultan R +6 more
europepmc +1 more source
Chenodeoxycholic acid activates the TGR5/TRPA1-5-HT pathway to regulate intestinal motility in breastfed infants and mouse models. [PDF]
Shan Z +6 more
europepmc +1 more source

